Mesa Laboratories MLAB Cash Flow Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| —— | -$1.97M+99.2% | -$254.25M-27,438% | $930K— | ||
| $5.25M-2.4% | $5.38M-53.0% | $11.45M-66.1% | $33.82M-16.1% | ||
| $17.87M+36.0% | $13.14M+10.1% | $11.94M-4.8% | $12.54M+10.1% | ||
| —— | $2.93M— | —— | —— | ||
| —— | -$1.15M+55.0% | -$2.56M-125% | $10.18M+874% | ||
| —— | —— | —— | -$1.55M-213% | ||
| $3.5M-63.2% | $9.5M— | —— | —— | ||
| —— | -$4.95M— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$608K-22.1% | -$498K-136% | -$211K— | —— | ||
| $18.02M-5.9% | $19.15M-30.0% | $27.34M— | —— | ||
| $0-100% | $2.89M— | $0— | $0— | ||
| $42.83M-8.5% | $46.81M+6.1% | $44.13M+57.7% | $27.98M-28.7% | ||
| $3.25M-23.5% | $4.25M+65.5% | $2.57M-43.5% | $4.54M+2.5% | ||
| $0-100% | $250K— | $0— | $0— | ||
| -$3.25M+27.8% | -$4.5M+94.5% | -$81.73M-761% | -$9.49M+96.9% | ||
| $3.52M+1.6% | $3.47M+0.6% | $3.45M+1.2% | $3.41M+2.0% | ||
| $36.75M-17.0% | $44.25M+32.1% | $33.5M-6.9% | $36M+71.4% | ||
| -$41.85M+6.0% | -$44.51M— | —— | -$33.33M— | ||
| $1.98M— | —— | -$359K— | —— | ||
| -$393K+56.0% | -$893K+81.0% | -$4.7M— | —— | ||
| $18.02M-5.9% | $19.15M-30.0% | $27.34M— | —— | ||
| $5.25M-2.4% | $5.38M+27.1% | $4.23M— | —— | ||
| —— | —— | —— | —— | ||
| -$608K-22.1% | -$498K-136% | -$211K— | —— | ||
| —— | -$1.97M+99.2% | -$254.25M-27,438% | $930K— | ||
| —— | -$4.95M— | —— | —— | ||
| $0-100% | $250K— | $0— | $0— | ||
| —— | —— | —— | —— | ||
| —— | —— | $0— | $0— | ||
| $36.75M-17.0% | $44.25M+32.1% | $33.5M-6.9% | $36M+71.4% | ||
| $0— | —— | $1.23M— | —— | ||
| $1.98M— | —— | -$359K— | —— | ||
| —— | —— | —— | —— | ||
| $9.56M— | $0— | $0— | —— | ||
| —— | —— | $71M— | —— | ||
| —— | —— | —— | —— | ||
| $39.58M-7.0% | $42.56M+2.4% | $41.57M+77.3% | $23.44M-32.6% | ||
| $39.58M-7.0% | $42.56M+2.4% | $41.57M+77.3% | $23.44M-32.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Mesa Laboratories generate?
- Mesa Laboratories (MLAB) generated $42.8M in operating cash flow over the trailing twelve months.
- What is Mesa Laboratories's free cash flow?
- After $3.3M of capital expenditures, Mesa Laboratories's free cash flow was $39.6M over the trailing twelve months, down 7.0% year over year.
- Where does Mesa Laboratories's cash flow data come from?
- Every line is extracted from Mesa Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
